An open, single-center, Phase ? basket study of EGFR-based nimotuzumab combined with PD-1 in the treatment of advanced esophageal cancer, advanced pancreatic cancer, advanced head and neck cancer, and RAS-wt colorectal cancer
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/85179
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Advanced esophageal cancer:PD-1 monoclonal antibody+nimotuzumab;Advanced pancretic cancer:PD-1 monoclonal antibody+nimotuzumab;Advanced head and neck tumor:PD-1 monoclonal antibody+nimotuzumab;RAS-WT-Advanced colorectal cancer:PD-1 monoclonal antibody+nimotuzumab
Primary outcome(s): Objective response rate,ORR
Study Design: Non randomized control
创建时间：
2022-08-15
